BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30198972)

  • 21. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
    Masangkay N; Basu S; Moghbel M; Kwee T; Alavi A
    Nucl Med Commun; 2014 Oct; 35(10):1038-46. PubMed ID: 25023997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.
    Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K
    Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer.
    Goense L; Heethuis SE; van Rossum PSN; Voncken FEM; Lagendijk JJW; Lam MGEH; Terhaard CH; van Hillegersberg R; Ruurda JP; Mook S; van Lier ALHMW; Lin SH; Meijer GJ
    Nucl Med Commun; 2018 Jan; 39(1):60-67. PubMed ID: 29023336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of prophylactic cranial irradiation and hippocampal sparing on
    Chammah SE; Allenbach G; Jumeau R; Boughdad S; Prior JO; Nicod Lalonde M; Schaefer N; Meyer M
    Radiother Oncol; 2021 May; 158():200-206. PubMed ID: 33667589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thalamic abnormalities in children with continuous spike-wave during slow-wave sleep: An F-18-fluorodeoxyglucose positron emission tomography perspective.
    Agarwal R; Kumar A; Tiwari VN; Chugani H
    Epilepsia; 2016 Feb; 57(2):263-71. PubMed ID: 26697846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detecting High-Dose Methotrexate-Induced Brain Changes in Pediatric and Young Adult Cancer Survivors Using [
    Baratto L; Singh SB; Williams SE; Spunt SL; Rosenberg J; Adams L; Suryadevara V; Iv M; Daldrup-Link H
    J Nucl Med; 2024 Jun; 65(6):864-871. PubMed ID: 38575193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Physiologic (18)F FSPG Uptake in Healthy Volunteers.
    Mosci C; Kumar M; Smolarz K; Koglin N; Stephens AW; Schwaiger M; Gambhir SS; Mittra ES
    Radiology; 2016 Jun; 279(3):898-905. PubMed ID: 26785040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT.
    Pujara AC; Raad RA; Ponzo F; Wassong C; Babb JS; Moy L; Melsaether AN
    Breast J; 2016 May; 22(3):264-73. PubMed ID: 26843433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Appropriate margin thresholds for isocontour metabolic volumetry of fluorine-18 fluorodeoxyglucose PET in sarcoma: a hybrid PET/MRI study.
    Lee H; Paeng JC; Hong SH; Yoo HJ; Cheon GJ; Lee DS; Chung JK; Kang KW
    Nucl Med Commun; 2016 Oct; 37(10):1088-94. PubMed ID: 27281357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
    Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA
    J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability of
    Jena A; Taneja S; Singh A; Negi P; Sarin R; Das PK; Singhal M
    AJR Am J Roentgenol; 2017 Sep; 209(3):662-670. PubMed ID: 28678576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining optimal tracer activities in pediatric oncologic whole-body
    Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF; Schäfer JF
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
    Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
    Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymmetry of cerebral glucose metabolism in very low-birth-weight infants without structural abnormalities.
    Park JH; Kim CS; Won KS; Oh JS; Kim JS; Kim HW
    PLoS One; 2017; 12(11):e0186976. PubMed ID: 29095842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease.
    Verclytte S; Lopes R; Lenfant P; Rollin A; Semah F; Leclerc X; Pasquier F; Delmaire C
    J Neuroimaging; 2016; 26(2):207-12. PubMed ID: 26031943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased FDG uptake on late-treatment PET in non-tumour-affected oesophagus is prognostic for pathological complete response and disease recurrence in patients undergoing neoadjuvant radiochemotherapy.
    Zschaeck S; Hofheinz F; Zöphel K; Bütof R; Jentsch C; Schmollack J; Löck S; Kotzerke J; Baretton G; Weitz J; Baumann M; Krause M
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1813-1822. PubMed ID: 28600646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (18)F-FDG PET/CT mean SUV and metabolic tumor volume for mean survival time in non-small cell lung cancer.
    Kurtipek E; Çayci M; Düzgün N; Esme H; Terzi Y; Bakdik S; Aygün MS; Unlü Y; Burnik C; Bekci TT
    Clin Nucl Med; 2015 Jun; 40(6):459-63. PubMed ID: 25742234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.